This on-demand course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for the two-hour continuing education course on responsible opioid prescribing per Med 13.03(3) of the Wisconsin Administrative Code.
This activity has been pre-approved for ABIM, ABA, ABP, ABO, ABOHNS, and ABPath MOC Part II credit. Approval for MOC Part II credit by other ABMS Boards may be found here. Participants who complete the activity by Dec. 3, 2018, will have their MOC credit submitted for 2018; after Dec. 3, 2018, MOC credits will be submitted for 2019.
Speaker: Michael McNett, MD, Medical Director for Chronic Pain, Aurora Greater Milwaukee South, WI and Physician Faculty, Opioid Prescribing Education Wisconsin Medical Society
Special Note: The post-live-presentation includes responses to attendee questions.
Release Date (enduring material): December 5, 2016
Expiration date: December 31, 2019
Brief Description and Scope
This program provides a comprehensive review of the Wisconsin Medical Examining Board’s (MEB) Opioid Prescribing Guideline (finalized November 2016). The scope and purpose of the guideline is “to help providers make informed decisions about acute and chronic pain treatment -pain lasting longer than three months or past the time of normal tissue healing. The guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.” However, the underlying principles upon which the guideline is based will often apply to palliative, cancer, and end-of-life patients because these patients’ opioid physiology is not fundamentally different from other patients, although their duration of use may be. A prescriber practicing according to these guidelines will be providing the best evidence-based treatments for patients needing pain relief. In addition, thanks to a clear understanding of the guidelines, prescribers can be confident that their opioid prescribing protocols remain in compliance with state licensure statutes.
At the end of this educational activity, participants should be able to:
• Describe the problems associated with drug diversion, misuse, addiction, and overdose deaths.
• Identify the rationale behind each of the Wisconsin MEB opioid prescribing guidelines for the treatment of acute as well as chronic pain.
• Recognize opioid abuse and intervene to wean patients from opioids both for aberrant behavior and for lack of benefit.
Method of Participation
This course consists of a synchronized audio of the recorded lecture. Prior to viewing the presentation, participants must complete a brief pre-test. After viewing the presentation, participants must complete an evaluation and a post-test in which they must answer at least 75% of the answers correctly in order to receive AMA PRA Category 1 Credit™. The participant cannot proceed to request credit until this score is achieved.
E-mail email@example.com for questions related to the educational content.
This activity is designed for Primary Care Physicians, Specialty Physicians,
Allied Health Professionals, Nurses, Social Workers, Professional Staff
No commercial support was used in creating this educational activity.
ADA Compliance Statement:
In accordance with the Americans with Disabilities Act, the Wisconsin Medical Society seeks to make this activity accessible to all. If you have a disability, which might require special accommodations, please call 608.442.3800.
Registration is not refundable. If you are unable to participate in an activity for which you are registered, you may have a substitute participate in your place.